RT Journal Article
SR Electronic
T1 1126 The micellar formulation of the TLR7 agonist MBS8(1V270) potentiates the effects of immune checkpoint inhibitors <em>in vivo</em>
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A1239
OP A1239
DO 10.1136/jitc-2023-SITC2023.1126
VO 11
IS Suppl 1
A1 Jensen, Simon
A1 Petersen, Morten Just
A1 Panina, Svetlana
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A1239.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.